Effects of Diet and Genetic Factors on Gut Dysbiosis in IBS

Similar documents
SIMPOSIO Il microbiota intestinale e la sua modulazione nelle patologie dell asse intestino cervello. Microbiota e IBS.

The role of gut microbiome in IBS

William D. Chey, MD, FACG. Page 1 of ACG Midwest Regional Postgraduate Course Copyright 2016 American College of Gastroenterology

IBS: overview and assessment of pain outcomes and implications for inclusion criteria

Functional Nutrition Approaches to Gut Health 20 CPEU Module accredited by Nutrition Mission

Microbiome GI Disorders

Antidepressant Medication use is Associated with Abdominal Symptoms in People without a Functional Gastrointestinal Diagnosis

Unlocking the mysteries of gut comfort

Gut microflora and estrogens: a new paradigm for breast cancer risk reduction. Dr. Kathleen Egan (Moffitt) Dr. Lusine Yaghjyan (UF)

The Role of Food in the Functional Gastrointestinal Disorders

Socioeconomic State & Intestinal Microbiota. Ali Keshavarzian, MD Rush University Medical Center Chicago, IL

Post-Infectious Irritable Bowel Syndrome. John K. Marshall MD Division of Gastroenterology McMaster University

The relationship between FODMAP intake and acute gastrointestinal symptoms in adults with IBS A novel analysis using the FAST Diary

The long-term impact of the low-fodmap diet for management of irritable bowel syndrome. Dr Miranda Lomer RD.

P A T I E N T H A N D B O O K

Full Duration Management of Hepatitis C in General Hospital via IT System ---- a case from Peking University People s Hospital

Environmental Enteric Dysfunction. Jean Humphrey for the SHINE Trial Research Group

Beyond the Scope: An Integrative Gastroenterologist s Approach to Digestive Disorders

THE ROLE OF MICROBIOME IN IBD

Targeted Therapies and Gut Microbiome in Renal Cell Carcinoma (RCC)

Probiotics in IBS. Dr. Partha Pratim Das Associate Professor Dhaka Medical college

Beyond the Scope: The Microbiome & The Future of Gastroenterology

9/12/2017. Introduction. NHMRC Recommendations. Food Standards Australia New Zealand (FSANZ) defines Dietary Fibre as follows:

Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider

Bloating, Flatulence, and

11/13/18. MICROBIOME AND THE BRAIN: How your gut impacts wellbeing. Approach. Lessons from Venice. Session One. Sue Langley

Module Outline. 1. Microbiome overview: getting a sense of the microbiome, research, what we know

Dietary Options for Inflammatory Bowel Disease

Gut Microbiome Essentials

William Chey, MD University of Michigan Ann Arbor, MI

The Gut Microbiome: 101 Justin Carlson University of Minnesota

Steven Sandberg-Lewis, ND, DHANP 049 SW Porter Street Portland, OR

Functional Dyspepsia

Update in Pediatric IBD: 2018

Gut Lung Axis Implication of the Gut Microbiota beyond its niche

UMHS-PUHSC JOINT INSTITUTE

Intestinal Microbiota in Health and Disease

MICROBIOM AND OBESITY HEINZ GYAKY 2018 BUDAPEST

HOW THE MICROBIOME AFFECTS OUR HEALTH

Irritable Bowel Syndrome Now. George M. Logan, MD Friday, May 5, :35 4:05 PM

IBS - Definition. Chronic functional disorder of GI generally characterized by:

The Role of Nutrition, Gut Microbiome, and Gut Permeability in Immunomodulation: The Celiac Disease and Type 1 Diabetes Paradigms

GROUP 5. Jerrold R. Turner Nathalie Delzenne Wenke Feng Reuben Wong Thierry Piche Yehuda Ringel Irina Kirpich Brant Johnson

SERUM CYTOKINES ARE ELEVATED IN PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) BUT LARGELY UNRELATED TO SYMPTOM CHARACTERISTICS

Faecalibacterium prausnitzii

Prevalence of Irritable Bowel Syndrome among Medical Students and Interns in Jeddah, Saudi Arabia

Corporate Medical Policy

Modulation of abdominal pain by probiotics. Anna Lyra, PhD DuPont Nutrition & Health

Fecal microbiota transplantation: The When,the How and the Don t. By Dr Rola Hussein

The enteric microbiota: Implications for IBD. Eugene B. Chang, M.D. University of Chicago

Weekly Prevalence of Symptoms USA vs. Colombia

UKLIN1693a, date of preparation: March 2013.

Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in irritable bowel syndrome (IBS)

Gut microbiota, metabolic syndrome, obesity and the nutrient sensor pathways

Stool Testing for the Microbiome - Ready for Primetime?

Microbiome and Metabolome Studies:

Ever wonder what s really happening on the inside?

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Unlocking the mysteries of gut comfort

Thornton Natural Healthcare s Better Health News

DOHaD ANZ. Rae-Chi HUANG MBBS, PhD, FRACP, DCH. A/Professor Telethon Kids Institute

FODMAPs: Emerging Science and Implications for Practice

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

Presented by Megan R. Sanctuary, MS University of California at Davis

Microbiome analysis: from concept to completion. Matthew Stoll MD,PhD,MSCS January 26, 2015

Outline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose

Functionele Maagdarmklachten als Stoornissen van Gut-Brain Interacties Leiden alle wegen naar Rome IV?

pissn: eissn: Journal of Neurogastroenterology and Motility

Clinical Policy Bulletin: Fecal Bacteriotherapy

IBS-D: The Role of Pathophysiology in Assessment and Treatment ReachMD Page 1 of 7

Irritable Bowel Syndrome Causes and Treatments

Therapeutic Manipulation of the Gut Microbiota in Patients with IBD

Peripheral and central factors in the pathophysiology of irritable bowel syndrome

CROI 2016 Review: Immunology and Vaccines

NEW KNOWLEDGE FROM WSER RESEARCH: GI SYMPTOMS DURING ULTRAMARATHON RUNNING

Bibliografia Microbiota

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA

... SELECTED ABSTRACTS...

PDF - AUTOIMMUNE DISEASE BACK PAIN EBOOK

Is there an anti-inflammatory diet in IBD?

GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH?

Gluten Free Alphabet Soup!

APDW 2016 Poster No. a90312

Spectrum of Diverticular Disease. Outline

Dietitian Connection Webinar: Dietary management of IBS the low FODMAP diet & other adjunct therapies. Presented by Shirley Webber and Dr Jane Varney

IBS The Physiologist s Perspective

Asthma and the Airway Microbiome: New Insights and Hypotheses

Microbiome and Asthma

Gut Mechanics During Stress: How Feed Efficiency and Growth Can be Influenced

Disclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome

Effects of probiotics in the treatment of alcoholic hepatitis: randomized controlled multicenter study

Issues at Hand. Inflammatory Bowel Disease Paradigm. Diet changes the fecal microbiome. Experience with diet in IBD

ROLE OF THE GUT BACTERIA

The Roadmap to FODMAP

Non coeliac gluten sensitivity: Clinical relevance and recommendations for future research

Whole Health in Your Practice - Applying CIH March Whole Health in Your Practice 14. APPLYING CIH. Lucky Sarah VETERANS HEALTH ADMINISTRATION

The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain

Food Choices and Alternative Techniques in Management of IBS: Fad Versus Evidence

Presenter. Irritable Bowel Syndrome. Objectives. Introduction. Rome Criteria. Irritable Bowel Syndrome 2/28/2018

Transcription:

Effects of Diet and Genetic Factors on Gut Dysbiosis in IBS Chung Owyang, MD Professor of Medicine Department of Gastroenterology University of Michigan Li-ping Duan*, MD Professor of Medicine Department of Gastroenterology Peking University Third Hospital

Gut Microbita---an important Organ Gut Microbita Bacteria, viruses, fungi About 3 pounds weight About 10 times as many cells as human About 100 times as many genes as humans Many diseases are associated with gut dysbiosis Metabolic diseases Allergies Autoimmune diseases IBD,IBS Tumors Mental disorders 2

BACKGROUND Gut microbiota altered in IBS patients IBS differed from controls with the ratio of Firmicutes/Bacteroidetes Diet may significantly affect gut microbiota Studies are carried in western countries mainly Genus Phylum Health IBS GASTROENTEROLOGY 2011;141:1792 1801; Gut 2012;61:997-1006 Clin Gastroenterol Hepatol Liu YX, Duan LP, et al., 2016;14(11):1602-1611.

AIM To examine the impacts of diet and racial factors (parallel studies conducted in Beijing and Ann Arbor) on the development of gut dysbiosis To identify differences in gut microbiota between healthy and 2 groups of IBS subjects on either a vegetarian or red meat diet To demonstrate that gut microbial alterations are responsible for IBS symptoms and increasing plasma cytokine ratios as well as gut permeability index

PROGRAM PLAN 30 health subjects 100 IBS patients 1.No GI symptoms 2. No antibiotic in one month 3. No chronic diseases 4. No SIBO 1. No organic GI conditions 2. No antibiotic in one month 3. Rome III subgrouping criteria 4. No SIBO 15 vegetarian & 15 meat eaters 50 vegetarian & 50 meat eaters GI and psychological questionnaire: The Hospital Anxiety and Depression (HAD) Scale Gastrointestinal Symptom Rating Scale-IBS (GSRS-IBS) Bristol Stool Form Scale (BSF) Short-Form 36 (SF-36) Diet questionnaire Physiological testing: Intestinal membrane permeability testing (lactulose/mannitol) Visceral pain testing PBMC cytokine levels Both at Ann Arbor and Peking 16s rdna sequencing and analysis: DNA Isolation MiSeq Illumina sequencing OTUS, Phylotype Assignment, Diversity Measurements

PROGESS IRB approval on Mar. 19, 2015 in Beijing UMHS-PUHSC Joint Institute for Translational and Clinical Research Fifth Sixth and Seventh Annual Joint Institute Two PUHSC PhD students received extensive training in microbome research at UMMS mentored by Dr. Owyang

Study Calendar and Progress-IBS PKUSC/UM Evaluations/Tests Visit 1 Visit 2 Interim Visit 3 Off Study ROME III Criteria 135/380 Medication review Assess Eligibility 98/360 Sign Informed Consent CRF & Surveys 61/46 Blood Collection Diet Recalls Stool Collection 59/26 6 hour urine collection Visceral Pain Testing 45/17 Completed the study 58/28 7

Study Calendar and Progress -Health Control PKUSC/UM Evaluations/Tests Visit 1 Visit 2 Interim Visit 3 Off Study GI symptoms screening Medication review 74/153 Assess Eligibility 50/122 Sign Informed Consent CRF & Surveys Blood Collection 38/57 Diet Recalls Stool Collection 38/44 6 hour urine collection Visceral Pain Testing 36/44

RESULTS PUHSC/UM Subject Type Demographic Comparison DEMOGRAPHIC HC (N = 30) IBS (N = 58) AGE 34.1±12.2 yrs. 33.7±10.5 yrs. NS SEX Female: 36.7% Male: 63.3% Female:25.9% Male: 74.1% NS RACE MONGOLOID=100% MONGOLOID=100% DIET DEMOGRAPHIC HIGH FAT : LOW FAT DIET = 33.3% : 66.7% MEAT = 100% HC (N = 26) HIGH FAT : LOW FAT DIET = 17.2% : 82.8% MEAT = 100% IBS (N = 19) AGE 48.4 ± 14.8 yrs. 46.3 ± 15.6 yrs. NS SEX Female: 73.0% Male: 27.0% Female: 94.7% Male: 5.3% NS RACE CAUCASIAN = 84.6% AFR.-AMERI. = 15.4% DIET MEAT = 50.0% VEGE. = 50.0% CAUCASIAN = 94.7% AFR.-AMERI. = 5.3% MEAT = 89.5% VEGE. = 10.5% P NS P NS NS?

RESULTS PUHSC/UM Gender Demographic Comparison Beijing HC IBS Female Male Ann Arbor

RESULTS PUHSC/UM Diet Demographic Comparison 90 80 70 60 50 HFD LFD 100 90 80 70 60 50 HFD LFD 40 40 30 30 20 20 10 0 IBS HC 10 0 IBS HC Beijing Ann Arbor

RESULTS PUHSC/UM Barostat Rectal Sensation RECTAL SENSATION HEALTHY CONTROL (N = 29) IBS (N = 44) P-VALUE FIRST SENSATION FIRST URGE-TO- DEFECATE STRONG URGE-TO- DEFECATE MAXIMUM TOLERATED MEAN =12.1 MMHG/ SD = 4.3MMHG MEAN =22.0 MMHG/ SD = 6.MMHG MEAN = 31.8MMHG/ SD = 8.5MMHG MEAN = 41.8MMHG/ SD = 9.5MMHG MEAN = 8.6MMHG/ SD = 3.1 MMHG 0.000 MEAN = 16.8MMHG/ SD = 4.8MMHG 0.001 MEAN = 25.0MMHG/ SD = 7.0MMHG 0.005 MEAN = 34.6MMHG/ SD = 9.1MMHG 0.047 RECTAL SENSATION HEALTHY CONTROL (N = 26) IBS (N = 19) P-VALUE 1 = In itia l fe e lin g FIRST SENSATION (MMHG) MEAN = 15.5 MMHG/ SD = 6.6 MMHG MEAN = 11.1/ SD = 6.0 MMHG 0.14 50 2= Initial feeling to defecate 3= U rge to defecate 4= M axim um tolerance HC FIRST URGE-TO- DEFECATE MMHG STRONG URGE-TO- DEFECATE MMHG MEAN = 21.5 MMHG/ SD = 7.1 MMHG MEAN = 29.3 MMHG/ SD = 9.9 MMHG MEAN = 18.9/ SD =7.2 MMHG MEAN = 27.1 MMHG/ SD = 10.9 MMHG 0.12 0.31 m m Hg 40 30 20 10 IB S MAXIMUM TOLERATED MMHG MEAN = 36.1 MMHG/ SD = 10.8 MMHG MEAN = 39.0 MMHG/ SD = 12.7 MMHG 0.21 1 2 3 4 0

FIRST SENSATION DIET RESULTS PUHSC LINEAR REGRESSION MODEL OF BAROSTAT PREDICTOR VARIBALE Β 95% CI LOWER 95% CI UPPER P-VALUE STRONG URGE-TO-DEFECATE DIET PREDICTOR VARIBALE Β 95% CI LOWER 95% CI UPPER P-VALUE HIGH FAT DIEAT -0.095-2.271 2.082 0.931 LOW FAT DIET 0 FIRST URGE-TO-DEFECATE DIET PREDICTOR VARIBALE Β 95% CI LOWER 95% CI UPPER P-VALUE HIGH FAT DIEAT -1.505-4.404 1.393 0.303 LOW FAT DIEAT 0 HIGH FAT DIEAT -1.304-5.580 2.971 0.544 LOW FAT DIEAT 0 MAXIMUM TOLERATED DIET PREDICTOR VARIBALE Β 95% CI LOWER 95% CI UPPER P-VALUE HIGH FAT DIEAT -0.337-5.322 4.647 0.893 LOW FAT DIEAT 0 Even though a non-significant difference, the subjects reporting with the identification of a high-fat diet showed trend of more hypersensitive compared to the subjects reporting with the identification of a low-fat diet in Beijing.

RESULTS UM LINEAR REGRESSION MODEL OF BAROSTAT FIRST SENSATION PREDICTOR VARIBALE Β 95% CI LOWER 95% CI UPPER P-VALUE DIET MEAT -.860-6.04 4.32 0.745 VEGETARIAN 0 FIRST URGE-TO-DEFECATE PREDICTOR VARIBALE Β 95% CI LOWER DIET 95% CI UPPER P-VALUE MEAT -.203-5.68 5.27 0.942 VEGETARIAN 0 Even though a non-significant difference, the subjects reporting with the identification of a meat diet were more hypersensitive related to First Sensation (mmhg) and First Urge-to-Defecate (mmhg) compared to the subjects reporting with the identification of a vegetarian diet in Ann Arbor

RESULTS PUHSC Permeability HC IBS P Lactulose 6h(ug/ml) 2.645(0.975,2.762) 4.805(1.325,5.405) 0.062 Mannitol 6h(ug/ml) 53.713(24.200,59.125) 66.528(27.475,78.300) 0.289 Lactulose/Mannitol 6h 0.045(0.035,0.056) 0.078(0.057,0.098) 0.021

RESULTS PUHSC IL-12 and IL-10 PBMC Cytokine Levels Beijing Ann Arbor IL-12(p40) in PBMC supernatant ( pg/ml) 6 5 4 3 2 1 0 Control (JC) p=0.04 IBS (J) IL-10 in PBMC supernatant (pg/ml) 8 7 6 5 4 3 2 1 0 Healthy control p=0.011 IBS

RESULTS PUHSC Inflammation correlates with visceral hypersensitivity R 2 =0.511,p<0.05 R 2 =0.43,p<0.05 Serum IL10/12 positively correlated with mmhg urge to defecation (suggesting lower inflammatory tone is correlated with less visceral hypersensitivity)

SUMMARY The IBS group has a significantly more female compared to the HC group in the Michigan; while more male subjects in Beijing, raising the possibility that different pathophysiology between IBS patients from the two countries. There was significantly higher visceral hypersensitivity in IBS group compared to HC in Beijing patient but no significant difference at UM. There is increased inflammatory tone in IBS patients both in Beijing and at UM and correlates with degree of visceral hypersensitivity. We observed few vegetarians among IBS patients at UM suggesting vegetarian diet may be a protective factor in IBS. In Beijing, IBS patients consume higher carbohydrate and protein diet compared to HC.

IMPACT First clinical IBS study with well-phenotyped cohorts (distinct racial populations and dietary habits) to determine the effects of diet and racial factors on gut dysbiosis in IBS Provide unique and novel information to develop hypothesisdriven studies, to compete for future external fundings including NSFC in China and NIH in USA

FUTURE PLAN Completing enrollment (15 more vegetarian IBS subjects and sample collections) Complete analysis the gut microbiome of the stool samples (16s RNA sequencing and metabolomics) Perform detail dietary analysis to assess correlations between dietary composition, visceral hypersensitivity and permeability as well as inflammatory tone. High quality publications

Thank you!